World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 2742463

Number of visits today: 736

Number of downloads: 2013831

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Ghauri MA, Raza A, Hayat U, Atif N, Iqbal HMN, Bilal M. Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis. Biochim Biophys Acta Gen Subj 2022;1866:130113. [PMID: 35202768 DOI: 10.1016/j.bbagen.2022.130113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]

For:

Ghauri MA, Raza A, Hayat U, Atif N, Iqbal HMN, Bilal M. Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis. Biochim Biophys Acta Gen Subj 2022;1866:130113. [PMID: 35202768 DOI: 10.1016/j.bbagen.2022.130113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]

Number	Citing Articles
1	Liu X, Yang B, Huang X, Yan W, Hu G. Identifying Lymph Node Metastasis-related Factors in Breast Cancer using Differential Modular and Mutational Structural Analysis.. [DOI: 10.1101/2022.09.06.506724] [Reference Citation Analysis]
2	Sabnis RW. Substituted 6,7-Dihydro-5 H -Benzo[7]annulene Compounds as Selective Estrogen Receptor Degraders for Treating Cancer. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.2c00342] [Reference Citation Analysis]
3	Dhiwar PS, Matada GSP, Raghavendra NM, Ghara A, Singh E, Abbas N, Andhale GS, Shenoy GP, Sasmal P. Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer. Med Chem Res. [DOI: 10.1007/s00044-022-02934-7] [Reference Citation Analysis]
4	Sabnis RW. 6,7-Dihydro-5 H -benzo[7]annulene Compounds as Selective Estrogen Receptor Degraders for Treating Cancer. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.2c00287] [Reference Citation Analysis]